Navigation Links
MEDRAD and PETNET Solutions Partner for Innovative FDG Delivery
Date:6/12/2008

WARRENDALE, Pa., June 12 /PRNewswire/ -- MEDRAD, INC., has signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned subsidiary of Siemens Medical Solutions USA, Inc. The agreement will enable health care providers to inject Fluorodeoxyglucose (FDG) for Positron Emission Tomography/Computed Tomography (PET/CT) imaging procedures in an innovative, new way. The partnership will leverage MEDRAD's soon to be introduced PET infusion system and multi-dose FDG packaging and delivery from PETNET Solutions. PET/CT Imaging has proven effective in diagnosing and staging certain forms of cancer.

(Logo: http://www.newscom.com/cgi-bin/prnh/20040309/MEDRADLOGO )

MEDRAD's PET infusion system, to be called Intego(TM), is designed to automatically extract a patient dose from a multi-dose vial and deliver it directly to the patient. The system is mobile and includes dosimetry, shielding, and a touchscreen interface -- all with precision, flexibility, and safety in mind.

PETNET Solutions has agreed to provide FDG to customers throughout its extensive, cyclotron-based radiopharmacy network in multi-dose vials and specially designed vial shields, which will allow for easy integration with MEDRAD's new system.

Michael Reitermann, chief executive officer, Molecular Imaging, Siemens Medical Solutions USA, Inc., commented, "In addition to our traditional delivery method, by providing FDG in multi-dose vials compatible with the MEDRAD PET infusion system across our extensive network, we have the opportunity to help improve the way FDG is being handled and delivered."

Alan Connor, director of global marketing for MEDRAD Molecular Imaging, said, "We are very pleased that PETNET Solutions is the first FDG provider to agree to provide FDG in a manner compatible with the Intego System across its entire network. From the beginning of this project, PETNET Solutions has been instrumental to the development of this system and is dedicated to providing the latest in safety and clinical performance to their customers."

MEDRAD will show the system at the annual Society of Nuclear Medicine (SNM) meeting in New Orleans, Louisiana, on June 13-16.

About MEDRAD

MEDRAD, INC., is a worldwide leading provider of medical devices and services that enable and enhance imaging procedures of the human body. Used in diagnostic imaging, MEDRAD's product offerings include a comprehensive line of vascular injection systems, magnetic resonance (MR) surface coils and patient care products, and equipment services. Total 2007 revenues were $525 million. MEDRAD is a 2003 recipient of the Malcolm Baldrige National Quality Award, the top honor a U.S. company can receive for quality and business excellence. The company's world headquarters is near Pittsburgh, Pennsylvania, in the United States. MEDRAD is an affiliate of Bayer AG.

The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subsidiary of Bayer AG, is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Diabetes Care and Pharmaceuticals divisions. The pharmaceuticals business operates under the name Bayer Schering Pharma AG. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Find more information at http://www.bayerhealthcare.com.

About PETNET Solutions

PETNET Solutions, a fully owned subsidiary of Siemens Medical solutions, operates the largest PET radiopharmacy network with over 44 radiopharmacies and distribution centers at multiple locations that produce and distribute PET radiopharmaceuticals to hospitals, clinics, and research facilities for PET imaging.

Cautionary statement regarding forward-looking statement.

Certain statements in this press release that are neither reported financial results nor other historical information are forward-looking statements, including but not limited to, statements that are predictions of or indicate future events, trends, plans or objectives. Undue reliance should not be placed on such statements because, by their nature, they are subject to known and unknown risks and uncertainties and can be affected by other factors that could cause actual results and MEDRAD's plans and objectives to differ materially from those expressed or implied in the forward-looking statements. MEDRAD, INC., undertakes no obligation to update publicly or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.


'/>"/>
SOURCE MEDRAD, INC.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MEDRAD(R) Revenues Grow 10 Percent in 2007
2. MEDRAD Mobile MR Injector Meets Challenges of MR Trailers
3. MEDRAD Plant Named IndustryWeek Magazine Award Finalist
4. MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners
5. National Staff Nurses Union Endorses Obama for President; UAN Leaders Cite Obamas Commitment to Working Families, Health Care Solutions
6. Authentidate and EncounterCare Form ExpressMD Solutions Joint Venture to Provide Telehealth Vital Signs Monitoring Systems Designed to Improve Chronic Illness Care for Patients
7. NCPA Statement on Sen. Baucus Medicare Bill Inclusion of Solutions for Medicare and Medicaid Reimbursement Problems
8. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization
9. SXC Health Solutions to provide technology services and support to major PBM
10. Thomson Reuters Adds Routes of Synthesis Data to Its Newport Horizon Premium and Newport Vision Premium Solutions
11. Natural Solutions Names 45 Must-Have Foods for Healthy Weight Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... ... 2017 , ... After raising nearly $30,000 on Kickstarter , about three-times ... at a discounted crowdfunding price on Indiegogo . , “Along with creating an ... to bring a fidget toy to the market that was made of superior quality ...
(Date:5/26/2017)... ... May 26, 2017 , ... “When the Stars Lead Home”: a poignant ... of published author Laura Weigel Douglas, an avid reader who lives in the Pacific ... sometimes feels like Green Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year ...
(Date:5/26/2017)... (PRWEB) , ... May 26, 2017 , ... Water damage ... Lee, New Jersey School District had left education officials with a number of critical ... replacement of the flooring had to be accomplished with little or no disruption to ...
(Date:5/24/2017)... ... 24, 2017 , ... NucleusHealth ™, advancing clinical practice ... Food and Drug Administration (FDA) 510(k) clearance for its Nucleus.io ... for medical image management. At the core is patented streaming technology that provides ...
(Date:5/24/2017)... ... May 24, 2017 , ... Myers Jackson is well ... the ability to sell luxury homes anywhere on the planet. The luxury home market ... from Hattiesburg to Houston city-scapes. A quick search of “11 Spyglass Hill Auction will ...
Breaking Medicine News(10 mins):
(Date:5/9/2017)... 9, 2017 Zimmer Biomet Holdings, Inc. (NYSE ... today announced it has earned a spot on ... The Company was ranked among 500 U.S. employers as ... Healthcare Equipment and Services. The annual ... anonymous, independent survey of over 30,000 employees across 25 ...
(Date:5/9/2017)... 2017  Semler Scientific, Inc. (OTCQB: SMLR), an ... improve the clinical effectiveness and efficiency of healthcare ... quarter ended March 31, 2017. ... to identify when preventive care options are appropriate, ... heart attacks or strokes occur," said Doug ...
(Date:5/6/2017)... , May 5, 2017   Provista , a proven ... than 200,000 customers, today announced Jim Cunniff as ... of executive and business experience to Provista, including most recently ... in California . He assumed his new ... is a great fit for Provista," says Jody Hatcher ...
Breaking Medicine Technology: